Detalhe da pesquisa
1.
Omalizumab for the Treatment of Multiple Food Allergies.
N Engl J Med
; 390(10): 889-899, 2024 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407394
2.
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
N Engl J Med
; 388(19): 1755-1766, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163622
3.
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 153(1): 173-181.e10, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815782
4.
Food allergies on a college campus.
Ann Allergy Asthma Immunol
; 132(5): 579-584, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296046
5.
A Review of Shared Decision-Making, Published Protocols, and Post-desensitization Strategies in Oral Immunotherapy (OIT).
Curr Allergy Asthma Rep
; 24(4): 173-197, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441821
6.
Treatment for food allergy: Current status and unmet needs.
J Allergy Clin Immunol
; 151(1): 1-14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998790
7.
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.
J Allergy Clin Immunol
; 151(6): 1558-1565.e6, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828080
8.
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Lancet
; 399(10322): 359-371, 2022 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065784
9.
A clinical focus on oral tolerance in the development, prevention, and management of food allergy.
Cell Immunol
; 386: 104693, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854214
10.
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
J Allergy Clin Immunol
; 149(4): 1373-1382.e12, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653515
11.
Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
J Allergy Clin Immunol
; 149(6): 2166-2170.e1, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026206
12.
Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
J Allergy Clin Immunol
; 150(5): 1144-1153, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716952
13.
Effective methods of clinical education.
Ann Allergy Asthma Immunol
; 128(3): 240-247, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864188
14.
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
J Allergy Clin Immunol
; 147(3): 992-1003.e5, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290772
15.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449234
16.
Mechanisms of oral immunotherapy.
Clin Exp Allergy
; 51(4): 527-535, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417257
17.
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
J Allergy Clin Immunol
; 146(4): 851-862.e10, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535135
18.
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
J Allergy Clin Immunol
; 146(4): 863-874, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659313
19.
Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
Allergy
; 75(6): 1337-1346, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034781
20.
Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies.
Ann Allergy Asthma Immunol
; 125(1): 90-96, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32057932